Charles River Laboratories International, Inc.
CRL- Exchange
- NYSE
- Industry
- Services-Commercial Physical & Biological Research
- SEC CIK
- 0001100682
In the last 90 days, Charles River Laboratories International, Inc. insiders filed 0 open-market purchases and 10 sales; 569 institutions reported holding it in 13F filings for Q2 2026, worth $12.9B in total; Harris Associates (Oakmark) is the only superinvestor holding it.
Holders of 5% or more of CRL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Charles River Laboratories International, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 6.90%3.52M shares | – | Apr 17, 20251 filing | Apr 17, 2025 | SEC |
| Invesco Ltd. | 13G | 5.50%2.70M shares | New | Feb 12, 20261 filing | Feb 12, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
8 Schedule 13D and 13G filings on Charles River Laboratories International, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 20269:59 AM ET | FMR LLCand 1 other | 13G/A | 10.20%4.87M shares | +1.40 ppfrom 8.80% | Aug 31, 2026 | SEC |
| Aug 13, 20262:19 PM ET | Invesco Ltd. | 13G | 6.20%2.98M shares | +1.30 ppfrom 4.90% | Jun 30, 2026 | SEC |
| Aug 6, 202610:17 AM ET | FMR LLCand 1 other | 13G/A | 8.80%4.24M shares | +1.80 ppfrom 7.00% | Jun 30, 2026 | SEC |
| May 6, 20263:45 PM ET | Invesco Ltd. | 13G/A | 4.90%2.40M shares | −0.60 ppfrom 5.50%Below 5% | Mar 31, 2026 | SEC |
| May 6, 202611:06 AM ET | FMR LLCand 1 other | 13G | 7.00%3.46M shares | – | Mar 31, 2026 | SEC |
| Apr 29, 20265:49 PM ET | Vanguard Capital Management LLC | 13G | 7.38%3.63M shares | New | Mar 31, 2026 | SEC |
| Mar 26, 20265:15 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | –Below 5% | Mar 13, 2026 | SEC |
| Feb 12, 20261:51 PM ET | Invesco Ltd. | 13G | 5.50%2.70M shares | New | Dec 31, 2025 | SEC |
| Feb 10, 202611:19 AM ET | Wellington Management Group LLPand 2 others | 13G/A | 3.60%1.75M shares | −2.90 ppfrom 6.50%Below 5% | Dec 31, 2025 | SEC |
| Nov 14, 20254:57 PM ET | Nomura Holdings Inc | 13G/A | 1.60%807.9K shares | −3.80 ppfrom 5.40%Below 5% | Sep 30, 2025 | SEC |
| Nov 12, 20259:33 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 6.50%3.19M shares | −1.90 ppfrom 8.40% | Sep 30, 2025 | SEC |
| Aug 14, 20255:41 PM ET | Nomura Holdings Inc | 13G | 5.40%2.68M shares | New | Jun 30, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 8.40%4.29M shares | – | Mar 31, 2025 | SEC |
| Apr 17, 20259:35 AM ET | BlackRock, Inc. | 13G/A | 6.90%3.52M shares | – | Mar 31, 2025 | SEC |
| Feb 9, 2023 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 31, 2023 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 24, 20231:56 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2022 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jan 28, 20221:54 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
| Feb 10, 2021 | Vanguard Group Inc | 13G/AOld format | – | – | – | SEC |
| Jan 26, 20216:52 PM ET | BlackRock Inc. | 13G/AOld format | – | – | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Charles River Laboratories International, Inc. shares.
No Form 144 notices for Charles River Laboratories International, Inc. are on file.